These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31749401)

  • 21. Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.
    Daoudi S; Bouzar M
    Mult Scler Relat Disord; 2016 Mar; 6():37-40. PubMed ID: 27063620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
    Pula JH; Kattah JC; Keung B; Wang H; Daily J
    J Neurol Sci; 2014 Oct; 345(1-2):209-12. PubMed ID: 25125046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of multiple sclerosis and new diagnostic criteria].
    Leray E; Vukusic S
    Rev Prat; 2016 Jan; 66(1):32-36. PubMed ID: 30512395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, incidence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.
    Houzen H; Kano T; Kondo K; Takahashi T; Niino M
    J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):494-495. PubMed ID: 36450477
    [No Abstract]   [Full Text] [Related]  

  • 25. A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.
    Papp V; Iljicsov A; Rajda C; Magyari M; Koch-Henriksen N; Petersen T; Jakab G; Deme I; Nagy F; Imre P; Lohner Z; Kovács K; Birkás AJ; Köves Á; Rum G; Nagy Z; Kerényi L; Vécsei L; Bencsik K; Jobbágy Z; Diószeghy P; Horváth L; Galántai G; Kasza J; Molnár G; Simó M; Sátori M; Rózsa C; Ács P; Berki T; Lovas G; Komoly S; Illes Z
    Eur J Neurol; 2020 Feb; 27(2):308-317. PubMed ID: 31465603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
    Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
    Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.
    Hagiwara A; Otsuka Y; Andica C; Kato S; Yokoyama K; Hori M; Fujita S; Kamagata K; Hattori N; Aoki S
    J Clin Neurosci; 2021 May; 87():55-58. PubMed ID: 33863534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
    Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
    Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
    Messina S; Mariano R; Geraldes R; Kim SH; Satukijcha C; Vecchio D; Chua YY; Taylor J; George N; Cavey A; Diaz AR; Reeve S; Everett R; De Luca G; Leite MI; Kim HJ; Palace J
    Mult Scler Relat Disord; 2021 Apr; 49():102773. PubMed ID: 33540279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
    Houzen H; Niino M; Hirotani M; Fukazawa T; Kikuchi S; Tanaka K; Sasaki H
    J Neurol Sci; 2012 Dec; 323(1-2):117-22. PubMed ID: 22995683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
    Rojas JI; Alonso Serena M; Garcea O; Patrucco L; Carrá A; Correale J; Vrech C; Pappolla A; Miguez J; Doldan ML; Silveira F; Alonso R; Cohen L; Pita C; Silva BA; Fiol M; Gaitán MI; Marrodan M; Negrotto L; Ysrraelit MC; Deri N; Luetic G; Caride A; Carnero Contentti E; Lopez PA; Pettinicchi JP; Curbelo C; Martinez AD; Steinberg JD; Balbuena ME; Tkachuk V; Burgos M; Knorre E; Leguizamon F; Piedrabuena R; Liwacki SDV; Barboza AG; Nofal P; Volman G; Alvez Pinheiro A; Hryb J; Tavolini D; Blaya PA; Silva E; Blanche J; Tizio S; Caceres F; Saladino ML; Zanga G; Fracaro ME; Sgrilli G; Pagani Cassara F; Vazquez G; Sinay V; Menichini ML; Lazaro L; Cabrera LM; Bestoso S; Divi P; Jacobo M; Kohler E; Kohler M; Giunta D; Mainella C; Manzi R; Parada Marcilla M; Viglione JP; Martos I; Reich E; Jose G; Cristiano E; Fernández Liguori N;
    Neurol Sci; 2020 Jun; 41(6):1513-1519. PubMed ID: 31960250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil.
    Papais-Alvarenga RM; Pereira FF; Bernardes MS; Papais-Alvarenga M; Batista E; Paiva CA; Santos CM; Vasconcelos CC
    J Neurol Sci; 2015 Sep; 356(1-2):196-201. PubMed ID: 26115914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD).
    Shaygannejad V; Sadeghi Bahmani D; Soleimani P; Mirmosayyeb O; Barzegar M; Amra B; Brand S
    Sleep Med; 2020 Jun; 70():97-105. PubMed ID: 32276200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics of Patients With Neuromyelitis Optica Spectrum Disorders With Early Onset.
    Fragoso YD; Sousa NAC; Saad T; Alves-Leon SV; Pimentel MLV; Goncalves MVM; Stella CV; Diniz DS; Santos GC; Gomes S; Adoni T; Anacleto A; Claudino R; Malfetano FR; Winckler TCD; Damasceno A; Eboni ACB; Farinhas JGD; Mota RSS
    J Child Neurol; 2019 Aug; 34(9):487-490. PubMed ID: 31012355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
    Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.
    Paz SPC; Branco L; Pereira MAC; Spessotto C; Fragoso YD
    Epidemiol Health; 2018; 40():e2018001. PubMed ID: 29370683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.